We found that such a treatment has no effect on MAPK signalling (Supplementary Fig. S9A), as well as on the expression of both HIF1A and glycolysis-related genes at multiple time points in both tumour cell lines (Supplementary Fig. S9B–F). Here, HIF1A is linked to neoplasm.